Aveo Promises Reforms In Cancer Drug Derivative Settlement
Aveo Pharmaceuticals Inc.'s board has agreed to reform itself and the company's internal policies following an investor's derivative suit claiming it lied about the success of a clinical trial for a...To view the full article, register now.
Already a subscriber? Click here to view full article